MWC Technologies

Chattanooga, United States Acquired By Zeus
Manufacturer of medical device components and cardiac ablation catheters

About MWC Technologies

MWC Technologies is a company based in Chattanooga (United States) was acquired by Zeus in June 2018. MWC Technologies operates in a competitive market with competitors including Orchestra BioMed, Biotronik, Inquis Medical, Synaptic Medical and Spectrumedics, among others.

  • Headquarter Chattanooga, United States
  • Sectors
    Healthcare
  • Website mwcte.com
  • Acquired by Zeus (Jun 2018)
Key Metrics

Investors in MWC Technologies

MWC Technologies has secured backing from 1 investor. Prominent investors backing the company include Zeus.

All
InvestorDescriptionFounded YearDomainLocation
Bio-polymer materials are manufactured for communication and automotive industries.
1966zeusinc.comOrangeburg, United States
Premium access

Investor details for MWC Technologies

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of MWC Technologies

1 people are tracked at MWC Technologies (1 in leadership).

NameRoleGroup
Steve Peterson
CEOLeadership
Premium access

Complete people profiles for MWC Technologies

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Competitors of MWC Technologies

MWC Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Orchestra BioMed, Biotronik, Inquis Medical, Synaptic Medical and Spectrumedics, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
orchestrabiomed.com2017New Hope, United States$205.88M–
Medical devices for hypertension and atherosclerosis treatment are developed.
biotronik.com1963Berlin, Germany–1,196
Cardiovascular products and equipment are developed, manufactured, and distributed.
inquismedical.com2019Redwood, United States$40M–
Developer of medical device for the treatment of peripheral thrombectomy
synapticmed.com2005Lake Forest, United States$60M–
Medical devices for cardiac arrhythmias and cardiovascular diseases are developed.
spectrumedics.com2018Singapore$14.99M–
Manufacturer of a therapeutic device for the treatment of arterial vascular calcification
pulsemed.cn2012Zhuhai, China$1.45M–
Cardiovascular medical devices are developed and manufactured in China.
cbmed.cn2018Shenzhen, China$14.04M–
Extracorporeal circulation products including ECMO are developed for medical support.
vigormt.com2014Haifa, Israel––
Devices for chest trauma treatment and drainage are developed.
med-zenith.com2005Beijing, China––
Electrosurgical devices for cardiovascular treatments are manufactured.
baylismedical.com1986Montreal, Canada–80
Medical products for cardiology, endovascular, and oncology are developed.
Premium access

Detailed competitors of MWC Technologies

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Mwc Technologies

Zeus Acquires MWC Technologies, LLC
Prnewswire β€’ 8 years ago
Premium access

Complete news archive for MWC Technologies

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to MWC Technologies

10 companies that operate in the same segment as MWC Technologies (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Connected devices for health, sleep, and activity monitoring are developed.
2008Moulineaux, Seine-maritime, FranceUSD 93.83 M––
SMT is recognized as a developer of cardiovascular medical devices.
1998Surat, Gujarat, IndiaUSD 57.22 MUSD 106.25 M1,090
Gene-editing therapies for coronary artery disease are developed.
2018Cambridge, Massachusetts, United StatesUSD 215.5 M–255
Cardiac monitoring devices and applications are provided for heart health.
2010Mountain View, California, United StatesUSD 114.38 MUSD 6.18 M67
Therapies for lowering low-density lipoprotein cholesterol levels are developed.
1998Ann Arbor, Michigan, United StatesUSD 129.7 MUSD 332.31 M304
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided.
2006San Francisco, California, United StatesUSD 109.23 MUSD 747.14 M2,000
Provider of neuroprotection devices for carotid artery disease
2007Sunnyvale, California, United StatesUSD 241.8 M––
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
2007East Peoria, Illinois, United StatesUSD 154.77 M–104
Access catheters for neurovascular stroke treatment are provided.
2015Campbell, California, United StatesUSD 596 M––
Biosensor patches are developed for monitoring multiple body vitals.
2011Campbell, California, United StatesUSD 239.95 M–184
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about MWC Technologies

MWC Technologies is headquartered in Chattanooga, United States. It is registered at Chattanooga, Tennessee, United States.

Steve Peterson is the current CEO of MWC Technologies.

Manufacturer of medical device components and cardiac ablation catheters. The company is developing polyimide tubing for cardiovascular, peripheral, and neurological catheters as well as urological retrieval devices used for electrophysiology, diagnostic, and cardiac ablation catheters.

MWC Technologies's top competitors include Orchestra BioMed, Biotronik and Inquis Medical.

MWC Technologies has 1 investor. Key investors include Zeus.

Yes. MWC Technologies was acquired by Zeus in June 2018.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available